Revive Therapeutics Ltd. - ROE
RVVTF
Price:
$0.018
Market Cap:
$13.07M
Revive Therapeutics Ltd., a life sciences firm founded in 2012 and headquartered in Toronto, Canada, is focused on discovering and advancing treatments for uncommon diseases and infectious illnesses. The company maintains a pharmaceutical pipeline centered on cannabinoids, specifically targeting rare inflammatory conditions. Key developments in its therapeutic portfolio include: Bucillamine: Currently in Phase 3 clinical trials, it is being investigated for combating infectious diseases such as influenza and COVID-19. Psilocybin: This compound is in Phase 1 clinical studies for its potential in treating methamphetamine use disorder. Psilocin: The company is exploring its application for a ra...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-12-02
Stock Exchange
OTC
Ticker
RVVTF
PE Ratio
[-0.90]
ROE
[288.66%]
Current Ratio
[0.04]
Dividend Yield
[0%]
Enterprise Value
[13.12M]
Dividend History
The ROE as of June 2026 (TTM) for Revive Therapeutics Ltd. (RVVTF) is 288.66%
According to Revive Therapeutics Ltd.’s latest financial reports and current stock price. The company's current ROE is 288.66%. This represents a change of 278.91% compared to the average of 76.18% of the last 4 quarters.
Revive Therapeutics Ltd. (RVVTF) Historical ROE (quarterly & annually)
How has RVVTF ROE performed in the past?
The mean historical ROE of Revive Therapeutics Ltd. over the last ten years is -103.16%. The current 288.66% ROE has changed -379.81% with respect to the historical average. Over the past ten years (40 quarters), RVVTF's ROE was at its highest in in the June 2025 quarter at 277.71%. The ROE was at its lowest in in the December 2018 quarter at -113.74%.
Average
-103.16%
Median
-88.87%
Minimum
-481.49%
Maximum
318.64%
Revive Therapeutics Ltd. (RVVTF) ROE by Quarter and Year
Discovering the peaks and valleys of Revive Therapeutics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 459.93%
Maximum Annual ROE = 318.64%
Minimum Annual Increase = -510.14%
Minimum Annual ROE = -481.49%
| Year | ROE | Change |
|---|---|---|
| 2025 | 318.64% | -510.14% |
| 2024 | -77.69% | 30.93% |
| 2023 | -59.34% | -58.07% |
| 2022 | -141.51% | 101.82% |
| 2021 | -70.11% | -3.21% |
| 2020 | -72.44% | -49.24% |
| 2019 | -142.72% | -30.35% |
| 2018 | -204.91% | 104.82% |
| 2017 | -100.04% | -79.22% |
| 2016 | -481.49% | 459.93% |
Revive Therapeutics Ltd. (RVVTF) Average ROE
How has RVVTF ROE performed in the past?
The current ROE of Revive Therapeutics Ltd. (RVVTF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
60.54%
5-year avg
-6.00%
10-year avg
-103.16%
Revive Therapeutics Ltd. (RVVTF) ROE vs. Peers
How is RVVTF’s ROE compared to its peers?
Revive Therapeutics Ltd.’s ROE is less than StateHouse Holdings Inc. (35.64%), less than Pharmadrug Inc. (28.90%), less than Cann Group Limited (93.89%), greater than Thunder Energies Corporation (0.12%), greater than Canntab Therapeutics Limited (-376.90%), greater than Rafarma Pharmaceuticals, Inc. (2.13%), greater than 1933 Industries Inc. (-11.09%), greater than Captiva Verde Wellness Corp. (-81.17%), less than Trees Corporation (24.07%), less than Stella Diagnostics Inc. (17.12%),
| Company | ROE | Market cap |
|---|---|---|
| 35.64% | $35.60K | |
| 28.90% | $270.58K | |
| 93.89% | $2.40M | |
| 0.12% | $12.20K | |
| -376.90% | $3.89K | |
| 2.13% | $4.13M | |
| -11.09% | $2.89M | |
| -81.17% | $9.95M | |
| 24.07% | $2.00M | |
| 17.12% | $1.01M |
Build a custom stock screener for Revive Therapeutics Ltd. (RVVTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revive Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Revive Therapeutics Ltd. (RVVTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Revive Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Revive Therapeutics Ltd.'s ROE?
How is the ROE calculated for Revive Therapeutics Ltd. (RVVTF)?
What is the highest ROE for Revive Therapeutics Ltd. (RVVTF)?
What is the 3-year average ROE for Revive Therapeutics Ltd. (RVVTF)?
What is the 5-year average ROE for Revive Therapeutics Ltd. (RVVTF)?
How does the current ROE for Revive Therapeutics Ltd. (RVVTF) compare to its historical average?